FdaApplication

NDA 216018

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSUN PHARMA INDUSTRIES LTD
application_typeNDA
approval_date2022-02-28

Products (2)

ProductActive ingredientStrengthDosage form
ASPRUZYO SPRINKLERANOLAZINE500MGGRANULE, EXTENDED RELEASE;ORAL
ASPRUZYO SPRINKLERANOLAZINE1GMGRANULE, EXTENDED RELEASE;ORAL

2 products